MarketPulse — Real-Time Financial News & Market Analysis

Palantir could become the operating system for enterprise AI through its integrated platform ecosystem, potentially achieving infrastructure-level economics similar to Microsoft over three years.

Galapagos and Gilead plan to jointly develop an Ouro T cell engager for autoimmune diseases, splitting acquisition costs while Galapagos leads development and Gilead commercializes, freeing $500M in Galapagos cash.

Galapagos and Gilead are in advanced partnership talks for a first-in-class T-cell engager for autoimmune diseases, with 50% cost-sharing and €500 million capital freed for Galapagos.

Law firm investigates Stellantis for potential securities violations after €22.2 billion charge announcement triggers 23.7% stock plunge to $7.28.

Arm Holdings stock rises 3% ahead of March 24 product event as Morgan Stanley predicts AI chiplet announcement targeting cloud computing customers.

Airlines rally on easing Iran tensions and declining oil prices. AAL up 3.64% to $10.81, though down 16% monthly amid persistent volatility.

Rosen Law Firm urges Kyndryl investors to retain counsel before April 13, 2026 deadline in securities class action over false financial disclosures.

Rep. Pfluger sells Warner Bros. Discovery stock despite 150% annual gain amid DOJ review of Paramount-Skydance merger.

Securities class action filed against $COTY for failing to disclose weakness in beauty and fragrance segments. Stock fell 22% following disappointing Q2 results and guidance withdrawal.

VanEck BDC Income ETF down 12% in 2026 as private credit turmoil spreads. BDCs trade at steep discounts to book value, potentially presenting opportunity.

Outlook Therapeutics launches best-efforts public offering of stock and warrants with H.C. Wainwright as placement agent, subject to market conditions.

Grocery Outlet CEO buys $1.7M in stock, doubling stake as company faces comparable sales decline and launches 36-store closure plan.

U.S. stocks rallied March 23 as Iran de-escalation signals sparked crude oil decline. S&P 500, Nasdaq, Dow each gained 1.15-1.38% on travel and industrial strength.

Major companies report earnings this week, including Ondas (strong $375M revenue outlook), GameStop (CEO Cohen's strategy review), and PDD (Temu expansion costs) alongside Carnival, Beyond Meat, and others.

Inventiva will release 2025 financial results March 30, 2026, while advancing lanifibranor in Phase 3 MASH trials.

Inventiva to release 2025 financial results March 30, 2026, as its lanifibranor MASH drug advances through Phase 3 clinical trials.

Centerra Gold files 2025 annual Form 40-F with SEC, including audited financials and MD&A, accessible via EDGAR and SEDAR+.

Weatherford to discuss Q1 2026 results April 22, secured multi-year Denmark completions contract.

Rosen Law Firm sues Richtech Robotics for allegedly fabricating Microsoft partnership claims. Affected investors must secure counsel before April 3 lead plaintiff deadline.

Bristol Myers Squibb's attractive 4.4% dividend yield faces headwinds from major patent expirations on blockbuster drugs Eliquis and Opdivo.